SEC Form 4 · accession 0002144542-26-000004
Viking Therapeutics, Inc. · VKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dorothy Elizabeth Kelly-Gemmell
Director
Period of report
Aug 1, 2026
Accepted (ET)
Aug 7, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001607678
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per shareF1 | Aug 1, 2026 | A | 6,333 | $0.00 | A | 6,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $31.74 | Aug 1, 2026 | A | 40,800 | A | Aug 1, 2027 | Aug 1, 2036 | Common Stock | 40,800 | 40,800 | D |
Explanation of responses
- F1Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
- F2One-third of the shares subject to the option will vest on each anniversary of the grant date.